These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 11906767)

  • 41. Induced atrophic rhinitis in rats.
    Kimman TG; Kamp EM
    Am J Vet Res; 1986 Nov; 47(11):2426-30. PubMed ID: 3789506
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Current prevention and therapy of atrophic rhinitis in swine with special reference to pathogen resistance].
    Moos M
    Berl Munch Tierarztl Wochenschr; 1988 Jan; 101(1):10-3. PubMed ID: 3348765
    [No Abstract]   [Full Text] [Related]  

  • 43. Analytical verification of a multiplex PCR for identification of Bordetella bronchiseptica and Pasteurella multocida from swine.
    Register KB; DeJong KD
    Vet Microbiol; 2006 Oct; 117(2-4):201-10. PubMed ID: 16782287
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Expression of the dermonecrotic toxin by Bordetella bronchiseptica is not necessary for predisposing to infection with toxigenic Pasteurella multocida.
    Brockmeier SL; Register KB
    Vet Microbiol; 2007 Dec; 125(3-4):284-9. PubMed ID: 17624695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Toxigenic type A Pasteurella multocida as a causative agent of nasal turbinate atrophy in swine.
    Sakano T; Taneda A; Okada M; Ono M; Hayashi Y; Sato S
    J Vet Med Sci; 1992 Jun; 54(3):403-7. PubMed ID: 1386531
    [TBL] [Abstract][Full Text] [Related]  

  • 46. An evaluation in pigs of Nobi-Vac AR and an experimental atrophic rhinitis vaccine containing P multocida DNT-toxoid and B bronchiseptica.
    Kobisch M; Pennings A
    Vet Rec; 1989 Jan; 124(3):57-61. PubMed ID: 2919495
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy of Bordetella bronchiseptica bacterin in controlling enzootic atrophic rhinitis in swine.
    Goodnow RA; Shade FJ; Switzer WP
    Am J Vet Res; 1979 Jan; 40(1):58-60. PubMed ID: 453686
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Significance of Bordetella bronchiseptica and Pasteurella multocida in rhinitis atrophicans suum].
    Kielstein P; Eliás B
    Zentralbl Veterinarmed B; 1985 Oct; 32(9):694-705. PubMed ID: 4072490
    [No Abstract]   [Full Text] [Related]  

  • 49. Identification of a 68-kilodalton outer membrane protein as the major protective antigen of Bordetella bronchiseptica by using specific-pathogen-free piglets.
    Kobisch M; Novotny P
    Infect Immun; 1990 Feb; 58(2):352-7. PubMed ID: 2137111
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Atrophic rhinitis of swine--a multifactorial disease?].
    Schöss P
    Berl Munch Tierarztl Wochenschr; 1989 Nov; 102(11):387-9. PubMed ID: 2686620
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Development of turbinate lesions and nasal colonization by Bordetella bronchiseptica and Pasteurella multocida during long-term exposure of healthy pigs to pigs affected by atrophic rhinitis.
    Bäckström LR; Brim TA; Collins MT
    Can J Vet Res; 1988 Jan; 52(1):23-9. PubMed ID: 3349398
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Immunization of rabbits against Pasteurella multocida using a commercial swine vaccine.
    Suckow MA
    Lab Anim; 2000 Oct; 34(4):403-8. PubMed ID: 11072861
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generation of an attenuated Salmonella-delivery strains expressing adhesin and toxin antigens for progressive atrophic rhinitis, and evaluation of its immune responses in a murine model.
    Byeon H; Hur J; Kim BR; Lee JH
    Vaccine; 2014 Sep; 32(39):5057-64. PubMed ID: 25045826
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interactions between Bordetella bronchiseptica and toxigenic Pasteurella multocida in atrophic rhinitis of pigs.
    Chanter N; Magyar T; Rutter JM
    Res Vet Sci; 1989 Jul; 47(1):48-53. PubMed ID: 2772406
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Intranasal administration of Pasteurella multocida toxin in a challenge-exposure model used to induce subclinical signs of atrophic rhinitis in pigs.
    van Diemen PM; de Jong MF; de Vries Reilingh G; van der Hel P; Schrama JW
    Am J Vet Res; 1994 Jan; 55(1):49-54. PubMed ID: 8141495
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Progress in the control of atrophic rhinitis caused by Bordetella bronchiseptica in swine.
    Switzer WP; Farrington DO
    J Am Vet Med Assoc; 1972 Dec; 161(11):1325-31. PubMed ID: 4565064
    [No Abstract]   [Full Text] [Related]  

  • 57. Effect of vaccination of sows with Bordetella bronchiseptica on the incidence of atrophic rhinitis in swine.
    Pedersen KB; Barfod K
    Nord Vet Med; 1977 Sep; 29(9):369-75. PubMed ID: 905119
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Cross-protection of recombinant Pasteurella multocida toxin proteins against atrophic rhinitis in mice.
    Wu MC; Lo YT; Wu HC; Wang HY; Chu CY
    Res Vet Sci; 2021 Jul; 137():138-143. PubMed ID: 33975192
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Protective effect by cell-free antigen obtained from culture supernatant of phase I Bordetella bronchiseptica.
    Ohgitani T; Uchida C; Okabe T; Sasaki N
    J Vet Med Sci; 1992 Feb; 54(1):37-42. PubMed ID: 1532748
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Immunogenicity and efficacy of three recombinant subunit Pasteurella multocida toxin vaccines against progressive atrophic rhinitis in pigs.
    Liao CM; Huang C; Hsuan SL; Chen ZW; Lee WC; Liu CI; Winton JR; Chien MS
    Vaccine; 2006 Jan; 24(1):27-35. PubMed ID: 16122849
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.